Delivery Order SPE2DB25D3110-SPE2DB25FTEGP
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,832.12 on August 28, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination inhaler used for maintenance...
- The Defense Logistics Agency awarded a delivery order valued at $21,488.46 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office and serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $12,237.62 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination maintenance inhaler used to treat chronic obstructive...
- The Defense Logistics Agency awarded a $10,547.87 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, due for completion by August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $16,902.11 delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on August 13, 2025, with completion scheduled for August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $7,178.56 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count), with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the company's corporate office in Conshohocken, Pennsylvania. Trelegy Ellipta is a prescription maintenance inhaler used to treat chronic obstructive pulmonary...
- The Defense Logistics Agency awarded a $6,017.40 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This firm fixed-price, non-set-aside contract is categorized as a delivery order under a larger indefinite delivery vehicle and will be performed at the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of September 4, 2025. Trelegy Ellipta is a combination respiratory...
- The Defense Logistics Agency awarded a $57,155.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on August 11, 2025, with completion targeted for August 12, 2025. This competitively awarded, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $2,059.98 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count supply). This firm fixed price, non-competitive delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination pharmaceutical product used in respiratory disease management,...
- The Defense Logistics Agency awarded a $28,030.14 delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination maintenance inhaler used to treat chronic obstructive pulmonary...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTEGPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,875.58 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count package). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be fulfilled from the vendor's operations in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. Trelegy Ellipta is a combination maintenance inhaler used in the treatment of chronic obstructive pulmonary disease and asthma. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a comprehensive prime indefinite delivery contract (SPE2DX) with DLA Troop Support Medical valued at $999.999 billion through December 2026. This strategic vehicle supports military healthcare programs globally by providing a broad range of pharmaceutical products, vaccines, and medical supplies to the Defense Health Agency and other federal healthcare systems. The company's continued selection for this delivery order reflects its established capability to meet federal medical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/4/25 |